Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012-2020.

IF 3.4 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Diabetology & Metabolic Syndrome Pub Date : 2025-01-31 DOI:10.1186/s13098-025-01604-z

Hassan Abu Obaid, Pedro Marques-Vidal

{"title":"Trends in diabetes mellitus and related costs among hospital admissions in Switzerland, 2012-2020.","authors":"Hassan Abu Obaid, Pedro Marques-Vidal","doi":"10.1186/s13098-025-01604-z","DOIUrl":null,"url":null,"abstract":"Background: In Switzerland, the prevalence of diabetes mellitus (DM) has increased in the general population, but little is known regarding DM-related hospitalizations and their impact on mortality and health costs. Hence, our objectives were to assess (1) the evolution of hospitalizations for DM as first diagnosis and as comorbidity; (2) the association of DM with ICU admission, length of stay (LOS), in-hospital mortality and costs.Methods: Swiss hospital discharge data for period 2012-2020. Type 1 (T1DM), type 2 (T2DM) and other types (OTDM) of DM were considered.Results: Between 2012 and 2020, the number of hospitalizations (% total) increased from 4204 (0.27) to 4980 (0.45) for T2DM, 539 (0.05) to 854 (0.08) for T1DM and 221 (0.02) to 381 (0.03) or OTDM. Hospitalizations with DM as comorbidity increased from 89,752 (8.6) to 128,700 (11.7) for T2DM, 2934 (0.29) to 3536 (0.32) or T1DM and 5774 (0.58) to 9143 (0.83) for OTDM. Compared to non-DM hospitalizations, all types of DM had a higher likelihood of lower limb amputation; hospitalizations for T1DM had a higher likelihood of ICU admission: odds ratio and 95% CI: 3.38 (3.19-3.59), while T2DM had higher LOS: 5.5 ± 1.0 vs. 5.1 ± 1.0 days, and all DM types had a lower odds of in-hospital mortality. Patients with any type of DM as comorbidity had a longer LOS than patients without. Total cost of DM rose from CHF 42 million in 2012 to almost 100 million in 2019 and decreased afterwards.Conclusion: DM represents an increasing health and economic burden in Switzerland.","PeriodicalId":11106,"journal":{"name":"Diabetology & Metabolic Syndrome","volume":"17 1","pages":"40"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783757/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology & Metabolic Syndrome","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13098-025-01604-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background: In Switzerland, the prevalence of diabetes mellitus (DM) has increased in the general population, but little is known regarding DM-related hospitalizations and their impact on mortality and health costs. Hence, our objectives were to assess (1) the evolution of hospitalizations for DM as first diagnosis and as comorbidity; (2) the association of DM with ICU admission, length of stay (LOS), in-hospital mortality and costs.

Methods: Swiss hospital discharge data for period 2012-2020. Type 1 (T1DM), type 2 (T2DM) and other types (OTDM) of DM were considered.

Results: Between 2012 and 2020, the number of hospitalizations (% total) increased from 4204 (0.27) to 4980 (0.45) for T2DM, 539 (0.05) to 854 (0.08) for T1DM and 221 (0.02) to 381 (0.03) or OTDM. Hospitalizations with DM as comorbidity increased from 89,752 (8.6) to 128,700 (11.7) for T2DM, 2934 (0.29) to 3536 (0.32) or T1DM and 5774 (0.58) to 9143 (0.83) for OTDM. Compared to non-DM hospitalizations, all types of DM had a higher likelihood of lower limb amputation; hospitalizations for T1DM had a higher likelihood of ICU admission: odds ratio and 95% CI: 3.38 (3.19-3.59), while T2DM had higher LOS: 5.5 ± 1.0 vs. 5.1 ± 1.0 days, and all DM types had a lower odds of in-hospital mortality. Patients with any type of DM as comorbidity had a longer LOS than patients without. Total cost of DM rose from CHF 42 million in 2012 to almost 100 million in 2019 and decreased afterwards.

Conclusion: DM represents an increasing health and economic burden in Switzerland.

查看原文本刊更多论文

2012-2020年瑞士住院患者糖尿病趋势及相关费用

背景：在瑞士，糖尿病（DM）的患病率在普通人群中有所增加，但对与DM相关的住院治疗及其对死亡率和医疗费用的影响知之甚少。因此，我们的目标是评估(1)糖尿病作为首次诊断和合并症的住院情况的演变；(2)糖尿病与ICU入院、住院时间（LOS）、住院死亡率和住院费用的关系。方法：2012-2020年瑞士医院出院数据。考虑1型（T1DM）、2型（T2DM）和其他类型（OTDM） DM。结果：2012 - 2020年，T2DM住院人数从4204人（0.27人）增加到4980人（0.45人），T1DM住院人数从539人（0.05人）增加到854人（0.08人），OTDM住院人数从221人（0.02人）增加到381人（0.03人）。合并糖尿病住院的T2DM患者从89,752例（8.6例）增加到128,700例（11.7例），T1DM患者从2934例（0.29）增加到3536例（0.32），OTDM患者从5774例（0.58）增加到9143例（0.83）。与非糖尿病住院相比，所有类型的糖尿病患者下肢截肢的可能性更高；T1DM患者入院ICU的可能性更高：比值比和95% CI: 3.38(3.19-3.59)，而T2DM患者的LOS更高：5.5±1.0 vs. 5.1±1.0天，所有DM类型的住院死亡率都较低。合并任何类型糖尿病的患者的LOS都比没有合并糖尿病的患者长。DM的总成本从2012年的4200万瑞士法郎上升到2019年的近1亿瑞士法郎，之后有所下降。结论：糖尿病是瑞士日益加重的健康和经济负担。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetology & Metabolic Syndrome ENDOCRINOLOGY & METABOLISM-

CiteScore

6.20

自引率

0.00%

发文量

170

审稿时长

7.5 months

期刊介绍： Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome. By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.